Skip to main content

Hongkou Capital LP

SEC CIK
0001852813
Latest filing
Nov 13, 2024

The latest 13F from Hongkou Capital LP covers Q3 2024 (filed Nov 13, 2024) and reports no long positions. Livermore has 13 filings on Form 13F from this institution, going back to Q4 2021.

What changed in Q3 2024

Share counts compared with Q2 2024: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
0
Added
0
Reduced
0
Sold out
8
Est. −$3.39M

Top 5 holdings

Share of this quarter's portfolio value

This filing reports no long positions.

Biggest buys

New and added positions, by estimated amount bought

None this quarter.

Largest weight increases

New and added positions, by percentage points of the portfolio gained

None this quarter.

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. GOTUGaotu Techedu Inc.
    −$1.15MSold outHistory
  2. WWayfair Inc.
    −$791.0KSold outHistory
  3. MRNAModerna, Inc.
    −$623.4KSold outHistory
  4. AGNTAGNT, Inc.
    −$397.3KSold outHistory
  5. STLNStarling Oncology, Inc.
    −$369.4KSold outHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. GOTUGaotu Techedu Inc.
    −33.82 pp33.8% → 0.0%History
  2. WWayfair Inc.
    −23.33 pp23.3% → 0.0%History
  3. MRNAModerna, Inc.
    −18.39 pp18.4% → 0.0%History
  4. AGNTAGNT, Inc.
    −11.72 pp11.7% → 0.0%History
  5. STLNStarling Oncology, Inc.
    −10.89 pp10.9% → 0.0%History

Metrics

13F metrics for Q3 2024, computed only from the numbers in the filings. Definitions below.

Portfolio value
$0
−$3.39M (−100.0%) vs. prior quarter
Positions
0
−8 vs. prior quarter
Top 10 concentration
–
Top 10 as share of value
Turnover
0.0%
Q3 2024, one quarter
Average holding period
–
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q4 2021), so positions held before then are understated.

13F filings by quarter

12 quarters, going back to Q4 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $101.1M (Q4 2021)

Q4 2021: $101.1MQ1 2022: $71.3MQ2 2022: $45.3MQ3 2022: $40.8MQ4 2022: $29.0MQ1 2023: $30.5MQ2 2023: $31.7MQ3 2023: $23.6MQ4 2023: $14.4MQ1 2024: $8.57MQ2 2024: $3.39M
Q4 2021Q3 2024
13F filings of Hongkou Capital LP by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q3 2024Nov 13, 20240$0–vs. Q2 2024SEC
Q2 2024Aug 14, 20248$3.39MGOTUWMRNAvs. Q1 2024SEC
Q1 2024May 13, 202415$8.57MGOTUSTLNPDDvs. Q4 2023SEC
Q4 2023Feb 13, 202422$14.4MSTLNPODDBEKEvs. Q3 2023SEC
Q3 2023Nov 3, 202338$23.6MCMAXWPODDvs. Q2 2023SEC
Q2 2023Sep 7, 2023Amended40$31.7MCMAXPODDAMDvs. Q1 2023SEC
Q1 2023May 3, 202340$30.5MCMAXPODDIOTvs. Q4 2022SEC
Q4 2022Feb 13, 202339$29.0MCMAXPODDIOTvs. Q3 2022SEC
Q3 2022Nov 14, 202240$40.8MCMAXPODDIOTvs. Q2 2022SEC
Q2 2022Aug 12, 202238$45.3MPODDGOOGLCMAXvs. Q1 2022SEC
Q1 2022May 12, 202236$71.3MPODDCMAXExscientia PLCvs. Q4 2021SEC
Q4 2021Feb 14, 202237$101.1MExscientia PLCPANWPODD–SEC